Search Browse Earnings

IR-Med, Inc.

OTC:IRME

Electromedical & Electrotherapeutic Apparatus·NEW YORK, NY

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$4.9M

FY 2024

Net Income

-$4.9M

FY 2024

EPS (Diluted)

-$0.07

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$767,000

FY 2024

Total Debt

$40,000

FY 2022

Net Cash

$727,000

FY 2022

Enterprise Value

—

Debt / EBITDA

0.1x

FY 2024

EV / EBITDA

—

Employees

—